Expression of Eukaryotic Initiation Factor 5A and Hypusine Forming Enzymes in Glioblastoma Patient Samples: Implications for New Targeted Therapies

Overview of attention for article published in PLOS ONE, August 2012

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 54 Dimensions

Readers on

mendeley: 49 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 54 publications that cite this research output.

54

The most recent citing publications are shown below. View all 54 publications that cite this research output on Dimensions.

Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings

Article in Brain Sciences (November 2023)

Unlocking the role of EIF5A: A potential diagnostic marker regulating the cell cycle and showing negative correlation with immune infiltration in lung adenocarcinoma

Article in International Immunopharmacology (November 2023)

Decreased eukaryotic initiation factors expression upon temozolomide treatment—potential novel implications for eIFs in glioma therapy

Article in Journal of Neuro-Oncology (October 2023)